260441-48-3

Basic information

• Product Name: 1-Piperidinecarboxylic acid, 4-(3,4-dichlorophenoxy)-, 1,1-dimethylethyl ester
• CAS NO: 260441-48-3
• Molecular Formula: C16H21Cl2NO3
• Molecular Weight: 346.254
• Mol File: 260441-48-3.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 1-Piperidinecarboxylic acid, 4-(3,4-dichlorophenoxy)-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperidinecarboxylic acid, 4-(3,4-dichlorophenoxy)-, 1,1-dimethylethyl ester(260441-48-3)
• EPA Substance Registry System: 1-Piperidinecarboxylic acid, 4-(3,4-dichlorophenoxy)-, 1,1-dimethylethyl ester(260441-48-3)

Safety Data

• Hazardous Substances Data: 260441-48-3(Hazardous Substances Data)

Upstream product

• 95-77-2 3,4-dichlorophenol 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 1972-28-7 diethylazodicarboxylate 

Downstream Products

• 1413286-14-2 C₂₄H₂₆Cl₂N₆O₂ 
• 1413286-15-3 C₂₇H₃₂Cl₂N₂O₆S 
• 1413286-16-4 C₂₆H₃₁Cl₂N₃O₄ 
• 1413286-17-5 C₂₉H₃₄Cl₂N₆O₄ 
• 367500-74-1 4-(3,4-dichloro-phenoxy)-[1,4']bipiperidine 
• 367500-72-9 4-(3,4-Dichloro-phenoxy)-[1,4']bipiperidinyl-1'-carboxylic acid tert-butyl ester 
• 367497-18-5 C₂₅H₂₈Cl₂N₂O₅ 
• 1413286-11-9 C₂₄H₂₆Cl₂N₂O₄ 
• 1413286-12-0 C₂₄H₂₆Cl₂N₂O₄ 
• 1413286-13-1 C₂₅H₂₆Cl₂N₄O₄ 
• 485391-81-9 C₂₃H₂₇Cl₂N₃O₄S 
• 245057-73-2 4-(3,4-dichloro-phenoxy)-piperidine 

Relevant articles and documents

The discovery of CCR3/H1 dual antagonists with reduced hERG risk

A series of dual CCR3/H1 antagonists based on a bispiperidine scaffold were discovered. Introduction of an acidic group overcame hERG liability. Bioavailability was optimised by modulation of physico-chemical properties and physical form to del

Chemical compounds

The invention provides compounds of formula (I): as modulators of chemokine and H1 receptor activity. The compounds are especially useful in the treatment of asthma and rhinitis.

Chemical compounds

The invention concerns compounds of formula (I), and their use in therapy, particularly in the modulation of CCR3 activity.